Literature DB >> 25632020

IGF-2R-Gαq signaling and cardiac hypertrophy in the low-birth-weight lamb.

Kimberley C W Wang1, Darran N Tosh1, Song Zhang1, I Caroline McMillen1, Jaime A Duffield1, Doug A Brooks2, Janna L Morrison3.   

Abstract

The cardiac insulin-like growth factor 2 receptor (IGF-2R) can induce cardiomyocyte hypertrophy in a heterotrimeric G protein receptor-coupled manner involving αq (Gαq) or αs (Gαs). We have previously shown increased left ventricular weight and cardiac IGF-2 and IGF-2R gene expression in low-birth-weight (LBW) compared with average-birth-weight (ABW) lambs. Here, we have investigated the cardiac expression of IGF-2 gene variants, the degree of histone acetylation, and the abundance of proteins in the IGF-2R downstream signaling pathway in ABW and LBW lambs. Samples from the left ventricle of ABW and LBW lambs were collected at 21 days of age. There was increased phospho-CaMKII protein with decreased HDAC 4 abundance in the LBW compared with ABW lambs. There was increased GATA 4 and decreased phospho-troponin I abundance in LBW compared with ABW lambs, which are markers of pathological cardiac hypertrophy and impaired or reduced contractility, respectively. There was increased histone acetylation of H3K9 at IGF-2R promoter and IGF-2R intron 2 differentially methylated region in the LBW lamb. In conclusion, histone acetylation of IGF-2R may lead to increased IGF-2R mRNA expression and subsequently mediate Gαq signaling early in life via CaMKII, resulting in an increased risk of left ventricular hypertrophy and cardiovascular disease in adult life.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  histone acetylation; insulin-like growth factor 2 receptor; low birth weight

Mesh:

Substances:

Year:  2015        PMID: 25632020      PMCID: PMC4385999          DOI: 10.1152/ajpregu.00346.2014

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  61 in total

1.  Restriction of placental growth results in greater hypotensive response to alpha-adrenergic blockade in fetal sheep during late gestation.

Authors:  Li Danielson; I Caroline McMillen; Jodie L Dyer; Janna L Morrison
Journal:  J Physiol       Date:  2005-01-13       Impact factor: 5.182

2.  Calmodulin kinase II inhibition protects against structural heart disease.

Authors:  Rong Zhang; Michelle S C Khoo; Yuejin Wu; Yingbo Yang; Chad E Grueter; Gemin Ni; Edward E Price; William Thiel; Silvia Guatimosim; Long-Sheng Song; Ernest C Madu; Anisha N Shah; Tatiana A Vishnivetskaya; James B Atkinson; Vsevolod V Gurevich; Guy Salama; W J Lederer; Roger J Colbran; Mark E Anderson
Journal:  Nat Med       Date:  2005-03-27       Impact factor: 53.440

3.  Intra-uterine growth restriction and the programming of left ventricular remodelling in female rats.

Authors:  Marie-Claude Battista; Ezequiel Calvo; Alzbeta Chorvatova; Blandine Comte; Jacques Corbeil; Michèle Brochu
Journal:  J Physiol       Date:  2005-03-17       Impact factor: 5.182

Review 4.  Regulation of cardiac contractile function by troponin I phosphorylation.

Authors:  Joanne Layland; R John Solaro; Ajay M Shah
Journal:  Cardiovasc Res       Date:  2005-04-01       Impact factor: 10.787

5.  Activity of cAMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts.

Authors:  U Kirchhefer; W Schmitz; H Scholz; J Neumann
Journal:  Cardiovasc Res       Date:  1999-04       Impact factor: 10.787

6.  The role of histone acetylation in the allelic expression of the imprinted human insulin-like growth factor II gene.

Authors:  J F Hu; H Oruganti; T H Vu; A R Hoffman
Journal:  Biochem Biophys Res Commun       Date:  1998-10-20       Impact factor: 3.575

7.  Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure.

Authors:  J W Adams; Y Sakata; M G Davis; V P Sah; Y Wang; S B Liggett; K R Chien; J H Brown; G W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

8.  Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death.

Authors:  A W Haider; M G Larson; E J Benjamin; D Levy
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

9.  Overlapping patterns of IGF2 and H19 expression during human development: biallelic IGF2 expression correlates with a lack of H19 expression.

Authors:  R Ohlsson; F Hedborg; L Holmgren; C Walsh; T J Ekström
Journal:  Development       Date:  1994-02       Impact factor: 6.868

10.  Promoter-specific IGF2 imprinting status and its plasticity during human liver development.

Authors:  T J Ekström; H Cui; X Li; R Ohlsson
Journal:  Development       Date:  1995-02       Impact factor: 6.868

View more
  7 in total

1.  Maternal undernutrition in late gestation increases IGF2 signalling molecules and collagen deposition in the right ventricle of the fetal sheep heart.

Authors:  Jack R T Darby; I Caroline McMillen; Janna L Morrison
Journal:  J Physiol       Date:  2018-05-20       Impact factor: 5.182

2.  Normalisation of surfactant protein -A and -B expression in the lungs of low birth weight lambs by 21 days old.

Authors:  Jia Yin Soo; Sandra Orgeig; Erin Victoria McGillick; Song Zhang; I Caroline McMillen; Janna L Morrison
Journal:  PLoS One       Date:  2017-09-26       Impact factor: 3.240

Review 3.  Near to One's Heart: The Intimate Relationship Between the Placenta and Fetal Heart.

Authors:  Emily J Camm; Kimberley J Botting; Amanda N Sferruzzi-Perri
Journal:  Front Physiol       Date:  2018-06-26       Impact factor: 4.566

4.  Sirt6 Deacetylase: A Potential Key Regulator in the Prevention of Obesity, Diabetes and Neurodegenerative Disease.

Authors:  Swapnil Raj; Liston Augustine Dsouza; Shailendra Pratap Singh; Abhinav Kanwal
Journal:  Front Pharmacol       Date:  2020-12-07       Impact factor: 5.810

Review 5.  Insulin-Like Growth Factor 2 As a Possible Neuroprotective Agent and Memory Enhancer-Its Comparative Expression, Processing and Signaling in Mammalian CNS.

Authors:  Alexander Beletskiy; Ekaterina Chesnokova; Natalia Bal
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

6.  Gastrodin Exerts Cardioprotective Action via Inhibition of Insulin-Like Growth Factor Type 2/Insulin-Like Growth Factor Type 2 Receptor Expression in Cardiac Hypertrophy.

Authors:  Jun Lu; Xin Ma; Wen-Cong Gao; Xin Zhang; Yuanling Fu; Qian Liu; Lixiang Tian; Xiao-Dan Qin; Weimin Yang; Hong-Yi Zheng; Chang-Bo Zheng
Journal:  ACS Omega       Date:  2021-06-21

Review 7.  Insulin-like growth factor-1 deficiency and metabolic syndrome.

Authors:  G A Aguirre; J Rodríguez De Ita; R G de la Garza; I Castilla-Cortazar
Journal:  J Transl Med       Date:  2016-01-06       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.